Long-Term Nevirapine Safe and Effective in Treating HIV, With No Deterioration of Lipid Profile: Presented at ECCMID
Long-term nevirapine (NVP)-based highly active antiretroviral therapy (HAART) is safe and effective for patients infected with HIV, with no deterioration seen in subjects lipid profiles, according to a retrospective study presented at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
19 de abril de 2010
The combination of protease inhibitors (PIs) with HAART -- a mainstay of treatment for patients with HIV infection -- is commonly associated with hypercholesterolaemia and hypertriglyceridaemia. The use of NVP, however, has provided a therapy with limited adverse effects on patients' lipid profiles, noted principal investigator Cristina Hidalgo, MD, Infectious Diseases Division, Fundación Jiménez Diaz, Madrid, Spain, speaking here on April 11.
Fuente: pslgroup.com
Ficheros disponibles
© 2023 Quirónsalud - Todos los derechos reservados
